Citations

Clear

7552 citation(s) found for "Ho, Matthew".

Appendicitis: Rural Patient Status is Associated with Increased Duration of Prehospital Symptoms and Worse Outcomes in High‐ and Low‐Middle‐Income Countries
Finnesgaard, Eric, Aho, Johnathon M. , Kong, Victor , Bruce, John , Polites, Stephanie F. , Laing, Grant , Clarke, Damian , Zielinski, Martin D. , Hernandez, Matthew C.

Mayo Clinic

World Journal of Surgery | November 13, 2017 | Volume: 42 | Issue: 6 | Pages: 1573-1580

10.1007/s00268-017-4344-5 | PMID 29134308 Get It

AbstractIntroductionAppendicitis is a significant economic and healthcare burden in low‐, middle‐, and high‐income countries. We aimed to determine whether urban and rural patient status would affect outcomes in appendicitis in a combined population regardless of country of economic status. We hypothesize that patients from rural areas and both high‐ and low‐middle‐income countries would have disproportionate outcomes and duration of symptoms compared to their urban counterparts.MethodsAdults (≥18 years) with appendicitis during 2010–2016 in South Africa and USA were reviewed using multi‐institutional data. Baseline demographic, operative details, durations of stay, and complications (Clavien–Dindo index) were collected. AAST grades were assigned by two independent reviewers based on operative findings. Summary, univariate, and multivariable analyses of rural and urban patients in both countries were performed.ResultsThere were 2602 patients with a median interquartile range [IQR] of 26 [18–40] years; 45% were female. Initial management included McBurney incisions (n = 458, 18%), laparotomy (n = 915, 35%), laparoscopic appendectomy (n = 1185, 45%), and laparoscopy converted to laparotomy (n = 44, 2%). Comparing rural versus urban patient status, there were increased overall median [IQR] AAST grades (3 [1–5] vs. 2 [1–3], p = 0.001), prehospital duration of symptoms (2 [1–5] vs. 2 [1–3], p = 0.001), complications (44.3 vs. 23%, p = 0.001), and need for temporary abdominal closure (20.3 vs. 6.9%, p = 0.001).ConclusionDespite socioeconomic status and country of origin, patients from more rural environments demonstrate poorer outcomes notwithstanding significant differences in overall disease severity. The AAST grading system may serve a potential benchmark to recognize areas with disparate disease burdens. This information could be used for strategic improvements for surgeon placement and availability.
Gender-Specific Differences in Serum Immunoglobulin E Levels and Prevalence of Fungus in Sinonasal Tissue Noted in Patients with Chronic Rhinosinusitis who Underwent Endoscopic Sinus Surgery
Azar, Antoine , Rank, Matthew A. , Zarka, Matthew A., Lai, Devyani, Chang, Yu‐Hui

Mayo Clinic

American Journal of Rhinology & Allergy | November 9, 2017 | Volume: 31 | Issue: 6 | Pages: 370-375

10.2500/ajra.2017.31.4471 | PMID 29122081 Get It

Background We previously presented that women with chronic rhinosinusitis (CRS) who elected endoscopic sinus surgery (ESS) have a higher symptom burden than men. Causes of these gender-based differences warranted further study. Objectives To study gender differences in another cohort of adult patients with CRS who underwent ESS and to compare key histopathologic and serologic features Methods Patients with CRS who underwent ESS (from 2011 to 2014) with structured histopathology reports on surgical samples were studied. The 13-item structured histopathology report detailed key metrics of inflammation and the presence of fungal elements. Clinical, 22-item Sino-Nasal Outcome Test (SNOT-22) score, Lund-Mackay computed tomography (CT) score, serologic (immunoglobulin E [IgE] level, absolute eosinophil count) and histopathologic data were compared between male and female patients by using statistical software. Results We studied 130 eligible subjects (mean age, 54.7 years; 49.2% women). Compared with the men, the women had significantly higher preoperative SNOT-22 scores (women, 48.7; men 38.0 [p = 0.004]) but similar CT scores. Serum IgE levels were significantly higher among women versus men (peak, 433.3 versus 190.8 kU/L [p = 0.03]; closest to surgery, 435.0 versus 190.8 kU/L [p = 0.03]). Tissue fungal elements were significantly more prevalent in women versus men (19.0 versus 5.2%; p = 0.02). Up to this point, the analysis was agnostic of clinical details of the subjects. Further analysis was conducted regarding clinical features. Allergic fungal sinusitis (AFS) was found significantly more commonly in the female versus male patients (21.9 versus 9.1%; p = 0.04). Women versus men had a higher prevalence of migraine (19.4 versus 4.6%; p = 0.01) or any primary headache disorders (23.0 versus 6.2%; p = 0.007). Conclusion Women who underwent ESS for CRS had higher SNOT-22 symptom burden. Worsened symptomatology may be secondary to a higher prevalence of primary headache disorders in women. However, surgeons should also be aware that female patients with CRS who seek ESS may have a higher prevalence of severe disease endotypes (more tissue fungal elements, elevated serum IgE levels) and phenotypes.
Cytomegalovirus (CMV) DNA quantification in bronchoalveolar lavage fluid of immunocompromised patients with CMV pneumonia
Beam, Elena , Germer, Jeffrey J., Lahr, Brian D. , Yao, Joseph D. , Binnicker, Matthew J. , Lahr, Brian, Yao, Joseph D C, Limper, Andrew Harold, Beam, Elena , Limper, Andrew H. , Razonable, Raymund R.

Mayo Clinic

Clinical Transplantation | November 7, 2017 | Volume: 32 | Issue: 1 | Pages: No page available

10.1111/ctr.13149 | PMID 29112278 Get It

AbstractCytomegalovirus (CMV) pneumonia causes major morbidity and mortality. Its diagnosis requires demonstration of viral cytopathic changes in tissue, entailing risks of lung biopsy. This study aimed to determine CMV viral load (VL) thresholds in bronchoalveolar lavage fluid (BALF) for diagnosis of CMV pneumonia in immunocompromised patients. CMV VL in BALF was studied in 17 patients (83% transplant recipients) and 21 control subjects with and without CMV pneumonia, respectively, using an FDA‐approved PCR assay (Cobas® AmpliPrep/Cobas TaqMan® CMV Test, Roche Molecular Systems, Inc.) calibrated to the WHO International Standard for CMV DNA (NIBSC: 09/162). Receiver operating characteristic curve analysis produced a BALF CMV VL threshold of 34 800, IU/mL with 91.7% sensitivity and 100.0% specificity for diagnosis of possible, probable, and proven CMV pneumonia in transplant patients, while a threshold of 656 000 IU/mL yielded 100% sensitivity and specificity among biopsy‐proven cases. For all immunocompromised patients, a VL threshold of 274 IU/mL was selected. VL thresholds also were normalized to BALF cell count yielding a threshold of 0.32 IU/106 cells with 91.7% sensitivity and 90.5% specificity for possible, probable, and proven CMV pneumonia in transplant recipients. Monitoring CMV VL in BALF may be a less invasive method for diagnosing CMV pneumonia in immunocompromised patients.
A Cross-sectional Survey of the North American Skull Base Society: Current Practice Patterns of Vestibular Schwannoma Evaluation and Management in North America
Wiet, Richard J., Tombers, Nicole M. , Link, Michael J. , Carlson, Matthew L. , Gompel, Jamie J. Van , Devaiah, Anand K. , Lal, Devyani , Morcos, Jacques J.

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | November 3, 2017 | Volume: 79 | Issue: 03 | Pages: 289-296

10.1055/s-0037-1607319 | PMID 29765827 Get It

Background Very few studies have examined vestibular schwannoma (VS) management trends across centers and between providers. The objective of this study is to examine current practice trends, variance in treatment philosophies, and nuanced or controversial aspects of VS care across North America. Methods This is a cross-sectional survey of North American Skull Base Society (NASBS) members who report regular involvement in VS care. Results A total of 57 completed surveys were returned. Most respondents claimed to have over 20 years of experience and the majority reported working in an academic practice with an affiliated otolaryngology and/or neurosurgery residency program. Sixty-three percent of respondents claimed to evaluate VS patients in clinic with both an otolaryngologist and neurosurgeon involved. Eighty-six percent of respondents claimed to operate on VS with both an otolaryngologist and neurosurgeon involved, while only 18% of neurosurgeons and 9% of otolaryngologists performed surgery alone. There was a wide range in the number of cases evaluated at each center annually. Similarly, there was wide variation in the number of patients treated with microsurgery and radiation at each center. Additional details regarding management preferences for microsurgery, stereotactic radiosurgery, stereotactic radiotherapy, and conservative observation are presented. Conclusion VS management practices vary between providers and centers. Overall, most centers employ a multidisciplinary approach to management with collaboration between otolaryngology and neurosurgery. Overall, survey responses concur with previous studies suggesting a shift toward conservatism in management.
A Cross-sectional Survey of the North American Skull Base Society on Vestibular Schwannoma, Part 2: Perioperative Practice Patterns of Vestibular Schwannoma in North America
Carlson, Matthew L. , Wiet, Richard J., Tombers, Nicole M. , M, Anand Devaiah, Link, Michael J. , Lal, Devyani , Morcos, Jacques J. , Gompel, Jamie J. Van

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | November 3, 2017 | Volume: 79 | Issue: 03 | Pages: 297-301

10.1055/s-0037-1607976 | PMID 29765828 Get It

Introduction Perioperative care of vestibular schwannoma (VS) patients is extremely variable across surgeons and institutions making practice patterns difficult to standardize. No data currently exist detailing this practice variability. Methods The North American Skull Base Society membership was electronically surveyed regarding perioperative care of surgically operated VS patients. Results There were 87 respondents to the survey. Surgical positioning, surgical approach utilized, and perioperative medical adjuncts are quite variable. However, of those performing retrosigmoid approaches, 49% perform this in the supine position, while 33% use a park-bench position with only 2% using the sitting position. In those performing translabyrinthine approaches, 86% perform this in supine position. Although the use of neuromonitoring appears to be standard of care (98%), other than the seventh nerve, there is substantial variability between respondents regarding monitoring of additional cranial nerves. Postoperative antibiotics are used by 65%, postoperative steroids 81%, and postoperative chemical deep vein thrombosis prophylaxis in 68% of survey respondents. Conclusion Although the perioperative adjuncts to VS surgery are variable, there does appear to be a trend in common practice. Therefore, making surgeons aware of these trends may lead to standardized practice or alternatively trials of these variances to instruct which truly improve patient outcomes.
Erdheim‐Chester Disease with atrial mass and perinephric calcification
Villatoro‐Villar, Michel , Koster, Matthew J.

Mayo Clinic

Clinical Case Reports | November 2, 2017 | Volume: 5 | Issue: 12 | Pages: 2153-2154

10.1002/ccr3.1258 | PMID 29225878 Get It

Key Clinical Message Erdheim‐Chester Disease is a multi‐systemic condition characterized by non‐Langerhans histiocytic infiltration. Cardiovascular involvement with pseudotumoral infiltration of the right atrium is present in approximately one‐third of patients and may be asymptomatic. Although retroperitoneal fibrosis is common, perinephric dystrophic calcification has not been previously described.
Predicting clinical decline in progressive agrammatic aphasia and apraxia of speech
Whitwell, Jennifer L. , Weigand, Stephen D. , Spychalla, Anthony J., Senjem, Matthew L. , Jack, Clifford R. , Josephs, Keith A. , Strand, Edythe A. , Jack, Clifford R , Senjem, Matthew L , Duffy, Joseph R. , Clark, Heather M. , Machulda, Mary M.

Mayo Clinic

Neurology | November 1, 2017 | Volume: 89 | Issue: 22 | Pages: 2271-2279

10.1212/wnl.0000000000004685 | PMID 29093069 Get It

PDX-MI: Minimal Information for Patient-Derived Tumor Xenograft Models
Meehan, Terrence F. , Goldstein, Theodore C. , Murakami, Mark A. , Brabetz, Sebastian , Gu, Zhiping , Wiser, Jeffrey A., Dunn, Patrick , Begley, Dale A. , Krupke, Debra M. , Bertotti, Andrea , Bruna, Alejandra , Brush, Matthew , Byrne, Annette T. , Caldas, Carlos , Christie, Amanda L., Clark, Dominic A. , Dowst, Heidi , Dry, Jonathan R. , Doroshow, James H. , Duchamp, Olivier, Ferretti, Stéphane , Frese, Kristopher K. , Goodwin, Neal , Greenawalt, Danielle M., Haendel, Melissa , Hermans, Els , Houghton, Peter J. , Jonkers, Jos , Kemper, Kristel , Khor, Tin Oo, Lloyd, K. C. Kent , Mason, Jeremy , Médico, Enzo , Olson, James M. , Peeper, Daniel S. , Seong, Je Kyung , Trusolino, Livio , Vinolo, Emilie, Wechsler‐Reya, Robert J. , Weinstock, David M. , Welm, Alana L. , Weroha, S. John , Pfister, Stefan M. , Kool, Marcel , Parkinson, Helen , Butte, Atul J. , Bult, Carol J. , Haendel, Melissa , Caldas, Carlos , Pfister, Stefan M , Conte, Nathalie , Inghirami, Giorgio , Evrard, Yvonne A. , Lewis, Michael T. , Neuhauser, Steven B. , Rueda, Oscar M. , Amant, Frédéric

Mayo Clinic

Cancer Research | November 1, 2017 | Volume: 77 | Issue: 21 | Pages: e62-e66

10.1158/0008-5472.can-17-0582 | PMID 29092942 Get It

Abstract Patient-derived tumor xenograft (PDX) mouse models have emerged as an important oncology research platform to study tumor evolution, mechanisms of drug response and resistance, and tailoring chemotherapeutic approaches for individual patients. The lack of robust standards for reporting on PDX models has hampered the ability of researchers to find relevant PDX models and associated data. Here we present the PDX models minimal information standard (PDX-MI) for reporting on the generation, quality assurance, and use of PDX models. PDX-MI defines the minimal information for describing the clinical attributes of a patient's tumor, the processes of implantation and passaging of tumors in a host mouse strain, quality assurance methods, and the use of PDX models in cancer research. Adherence to PDX-MI standards will facilitate accurate search results for oncology models and their associated data across distributed repository databases and promote reproducibility in research studies using these models. Cancer Res; 77(21); e62–66. ©2017 AACR.
Electronic Health Record Phenotypes for Precision Medicine: Perspectives and Caveats From Treatment of Breast Cancer at a Single Institution
Breitenstein, Matthew K. , Pathak, Jyotishman , Zhang, Rui , Liu, Hongfang , Maxwell, Kara N.

Mayo Clinic

Clinical and Translational Science | October 30, 2017 | Volume: 11 | Issue: 1 | Pages: 85-92

10.1111/cts.12514 | PMID 29084368 Get It

AbstractPrecision medicine is at the forefront of biomedical research. Cancer registries provide rich perspectives and electronic health records (EHRs) are commonly utilized to gather additional clinical data elements needed for translational research. However, manual annotation is resource‐intense and not readily scalable. Informatics‐based phenotyping presents an ideal solution, but perspectives obtained can be impacted by both data source and algorithm selection. We derived breast cancer (BC) receptor status phenotypes from structured and unstructured EHR data using rule‐based algorithms, including natural language processing (NLP). Overall, the use of NLP increased BC receptor status coverage by 39.2% from 69.1% with structured medication information alone. Using all available EHR data, estrogen receptor‐positive BC cases were ascertained with high precision (P = 0.976) and recall (R = 0.987) compared with gold standard chart‐reviewed patients. However, status negation (R = 0.591) decreased 40.2% when relying on structured medications alone. Using multiple EHR data types (and thorough understanding of the perspectives offered) are necessary to derive robust EHR‐based precision medicine phenotypes.